Myomar Molecular is developing a diagnostic tool to identify early stages of muscle atrophy. This technology will be used by physiotherapists and medical doctors to access therapy approaches, reduce hospitalization time, and analyze recovery progress.
This company has no teams yet
This company has no offices yet